Winter Hauke, Meimarakis Georgios, Hoffmann Gabriele, Hummel Manuela, Rüttinger Dominik, Zilbauer Astrid, Stelter Klaus, Spelsberg Fritz, Jauch Karl-Walter, Hatz Rudolph, Löhe Florian
Department of Surgery, University of Munich, Grosshadern Campus, Marchioninistrasse 15, Munich, 81377, Germany.
Ann Surg Oncol. 2008 Oct;15(10):2915-26. doi: 10.1245/s10434-008-0001-4. Epub 2008 Jul 22.
The prognosis of patients with metastasized head and neck cancer is poor. Limited experience exists with the benefit of resection of lung metastases and systematic mediastinal and hilar lymph node dissection on survival of patients with head and neck carcinoma.
Eighty patients undergoing metastasectomy for pulmonary metastases of primary head and neck cancer entered the study. Multivariate analysis was performed by Cox regression analysis. Survival differences between patients operated and those not operated on were analyzed by matched pair analysis.
From 1984 until 2006, pulmonary metastases were diagnosed in 332 patients treated for head and neck cancer; 80 of these were admitted to our department for resection. Metastases of the primary head and neck tumor were confirmed histologically in 67 patients. The median overall survival after resection of lung metastases was 19.4 months and was statistically significantly better compared with patients who were not operated on (P < .001). The multivariate analysis after metastasectomy revealed that incomplete resection of pulmonary lesions, complications associated with surgery, and adjuvant therapy of the primary tumor are independent negative prognostic factors for survival. We observed a trend to improved survival in patients without hilar or mediastinal lymph node metastases.
The survival rate of patients operated on was statistically significantly higher than that of patients with conservative treatment. Even patients with multiple or bilateral pulmonary lesions after curative treatment of a primary tumor should be operated on if there is no contraindication against an extended surgical procedure and a complete resection of the metastases seems achievable.
转移性头颈癌患者的预后较差。对于头颈癌患者,肺转移瘤切除及系统性纵隔和肺门淋巴结清扫对生存获益的经验有限。
80例因原发性头颈癌肺转移而接受转移瘤切除术的患者进入本研究。采用Cox回归分析进行多因素分析。通过配对分析比较手术患者与未手术患者的生存差异。
1984年至2006年期间,332例接受头颈癌治疗的患者被诊断为肺转移;其中80例转入我科接受切除术。67例患者经组织学证实为原发性头颈肿瘤转移。肺转移瘤切除术后的中位总生存期为19.4个月,与未手术患者相比有统计学显著差异(P <.001)。转移瘤切除术后的多因素分析显示,肺病变切除不完全、手术相关并发症及原发肿瘤的辅助治疗是生存的独立负性预后因素。我们观察到无肺门或纵隔淋巴结转移患者的生存有改善趋势。
手术患者的生存率在统计学上显著高于保守治疗患者。即使是原发性肿瘤根治性治疗后出现多发或双侧肺病变的患者,如果没有扩大手术的禁忌证且似乎可实现转移瘤的完整切除,也应接受手术治疗。